[pubmed] Clinical effect of tacrolimus in the treatment of myasthenia gravis in children
Posté : 16 sept. 2020 12:00
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Sep;22(9):964-969.
ABSTRACT
OBJECTIVE: To evaluate the efficacy and safety of tacrolimus in the treatment of children with myasthenia gravis (MG).
METHODS: A total of 28 children with MG were treated with tacrolimus. MG-Activities of Daily Living (MG-ADL) scale was used to assess clinical outcome and safety after 1, 3, 6, 9, and 12 months of treatment.
RESULTS: After tacrolimus treatment, the MG-ADL score at 1, 3, 6, 9 and 12 months was lower than that at baseline (P
Source: https://pubmed.ncbi.nlm.nih.gov/3293362 ... 0&v=2.11.5